Symbol
| MANF
| contributors: mct/npt/pgu - updated : 04-06-2015
|
HGNC name
| mesencephalic astrocyte-derived neurotrophic factor
|
HGNC id
| 15461
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
| somatic mutation
|  
|  
|  
|
in renal cell carcinoma | tumoral
| somatic mutation
|  
|  
|  
|
squamous cell carcinoma of the head and neck, lung, breast, pancreas and prostate carcinomas | constitutional
|  
|  
| --over
|  
|
in the early stage of cerebral ischemia | constitutional
|  
|  
|  
| gain of function
|
by endoplasmic reticulum (ER) stress | |
Variant & Polymorphism
|
| |
Candidate gene
| specifically promotes beta cell proliferation and survival, thereby constituting a therapeutic candidate for beta cell protection and regeneration |
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
neurology | neurodegenerative | Parkinson/dementia Parkinsonism | |
selective, neuroprotective effect of MANF for dopaminergic neurons suggests that it may be indicated for the treatment of Parkinson disease |
| | |
| Manf-deficient mice that strikingly develop severe diabetes due to progressive postnatal reduction of beta cell mass, caused by decreased proliferation and increased apoptosis |